Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126407611 | 12640761 | 1 | I | 20100418 | 20100422 | 20160810 | 20160810 | EXP | GB-ASTELLAS-2010001618 | ASTELLAS | 52.29 | YR | F | Y | 0.00000 | 20160810 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126407611 | 12640761 | 1 | PS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Oral | UNK, ONCE DAILY | Y | 0 | FORMULATION UNKNOWN | QD | |||||||
| 126407611 | 12640761 | 2 | SS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | 0 | FORMULATION UNKNOWN | |||||||||||
| 126407611 | 12640761 | 3 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 60 | MG | U | 0 | 6 | MG | FORMULATION UNKNOWN | BID | ||||
| 126407611 | 12640761 | 4 | C | RANITIDINE. | RANITIDINE | 1 | Oral | U | 0 | 150 | MG | FORMULATION UNKNOWN | BID | ||||||
| 126407611 | 12640761 | 5 | C | NICOTINE. | NICOTINE | 1 | Topical | U | 0 | 14 | MG | FORMULATION UNKNOWN | |||||||
| 126407611 | 12640761 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | U | 0 | 600 | MG | FORMULATION UNKNOWN | TID | ||||||
| 126407611 | 12640761 | 7 | C | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | U | 0 | 300 | MG | FORMULATION UNKNOWN | TID | ||||||
| 126407611 | 12640761 | 8 | C | FENTANYL. | FENTANYL | 1 | Topical | U | 0 | 12.5 | MG | FORMULATION UNKNOWN | |||||||
| 126407611 | 12640761 | 9 | C | ESTRADIOL W/LEVONORGESTREL | 2 | Oral | U | 0 | 2 | MG | FORMULATION UNKNOWN | QD | |||||||
| 126407611 | 12640761 | 10 | C | LORATADINE. | LORATADINE | 1 | Oral | U | 0 | 10 | MG | FORMULATION UNKNOWN | QD | ||||||
| 126407611 | 12640761 | 11 | C | SALBUTAMOL | ALBUTEROL | 1 | Unknown | UNK, PUFFS | U | 0 | FORMULATION UNKNOWN | ||||||||
| 126407611 | 12640761 | 12 | C | TRAMADOL. | TRAMADOL | 1 | Oral | UNK, AS NEEDED | U | 0 | FORMULATION UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126407611 | 12640761 | 1 | Non-small cell lung cancer |
| 126407611 | 12640761 | 2 | Metastases to central nervous system |
| 126407611 | 12640761 | 3 | Metastases to central nervous system |
| 126407611 | 12640761 | 4 | Product used for unknown indication |
| 126407611 | 12640761 | 5 | Product used for unknown indication |
| 126407611 | 12640761 | 6 | Pain |
| 126407611 | 12640761 | 7 | Depression |
| 126407611 | 12640761 | 8 | Pain |
| 126407611 | 12640761 | 9 | Menopause |
| 126407611 | 12640761 | 10 | Product used for unknown indication |
| 126407611 | 12640761 | 11 | Dyspnoea |
| 126407611 | 12640761 | 12 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126407611 | 12640761 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126407611 | 12640761 | Dyspnoea | |
| 126407611 | 12640761 | Metabolic acidosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126407611 | 12640761 | 1 | 20100412 | 20100419 | 0 | |
| 126407611 | 12640761 | 3 | 20100414 | 20100419 | 0 | |
| 126407611 | 12640761 | 4 | 20100419 | 0 | ||
| 126407611 | 12640761 | 5 | 20100419 | 0 | ||
| 126407611 | 12640761 | 6 | 20100419 | 0 | ||
| 126407611 | 12640761 | 7 | 20100419 | 0 | ||
| 126407611 | 12640761 | 8 | 20100419 | 0 | ||
| 126407611 | 12640761 | 10 | 20100419 | 0 | ||
| 126407611 | 12640761 | 12 | 20100419 | 0 |